C
Collegium Pharmaceutical, Inc.
COLL · NASDAQ · Healthcare · 916M
Closing price
$22.09
-0.09% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
11.1×
Price / net assetsP/B
2.3×
Enterprise value / EBITDAEV/EBITDA
3.5×
Free cash flow yieldFCF yield
46.8%
Return on equityROE
20.8%
Operating margin
24.0%
Net debt / EBITDAbalance-sheet strength
1.7×
Interest coverage
2.3×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.